NF Trinity Capital’s Celgene CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
NF Trinity Capital's CELG Position: Q1 2019 in Review
NF Trinity Capital sold out of Celgene (CELG) in Q1 2019, closing a stake of 107,491 shares — an estimated $6.89M sold.
NF Trinity Capital first reported a position in CELG in Q4 2015 and held it in 13 quarters. The position peaked at $18M in Q3 2016. 1,390 funds tracked by Wall St. Rank hold CELG as of Q1 2019.
- NF Trinity Capital reported no remaining Celgene position as of Q1 2019 after selling out during the quarter.
- NF Trinity Capital sold 107,491 Celgene shares in Q1 2019, an estimated $6.89M.
- NF Trinity Capital first reported a position in Celgene in Q4 2015 and held it in 13 quarters.
- NF Trinity Capital's Celgene position peaked at $18M in Q3 2016.
- 1,390 funds tracked by Wall St. Rank held Celgene as of Q1 2019.
Based on NF Trinity Capital's 13F filing for Q1 2019, filed 10 May 2019.